The Most Significant Cancer Research Advances of the 2010s

It was a decade that began with the electrifying results of a clinical trial for a revolutionary new cancer therapy and ended with a Nobel Prize in Medicine for very different cancer-related research. In between those dramatic bookends, the 2010s were packed with progress, with discoveries leading to the FDA’s 2017 approval of the first … Read more

Adult Leukemia: What You Need to Know

More than 60,000 new cases of adult leukemia are diagnosed in the U.S. each year. Although it is one of the more common childhood cancers, leukemia occurs more often in older adults. How does leukemia develop in adults? Leukemia is a cancer of the body’s blood-forming tissues that results in large numbers of abnormal or immature white blood … Read more

Pediatric Kidney Cancer Survivor Pays it Forward

Three-year-old Lia Scagnoli skipped across the “Bridge of Hope” connecting Boston Children’s Hospital and Dana-Farber Cancer Institute each time she had a chemotherapy infusion or other treatment for pediatric kidney cancer at Dana-Farber’s Jimmy Fund Clinic. Caregivers offering equal parts love, hope, and fun diversions gave her and her family a feeling of confidence that … Read more

Stella’s Story: Winning Against Neuroblastoma

This post originally appeared on Discoveries, the blog of Boston Children’s Hospital. The Downey family was enjoying the holidays with family in Guatemala in 2017 when their 13-month-old daughter Stella started having unusual symptoms. “She was very clingy towards me and not acting like herself,” says Stella’s mom, Fiorella, a child life specialist at Boston … Read more

For Teen With Rare Genetic Condition, Endocrine-Oncology Treatment Proves a Master Class

Felicia Walbridge has long been interested in biomedical engineering, and plans on majoring in the field during college. Until recently, the teenager’s experience in this area was limited primarily to reruns of the TV show “Grey’s Anatomy.” Then, with little warning, Walbridge became the star of her very own medical drama — complete with a … Read more

Immunotherapy for Cancer: What it Is, How it Works, and Where it’s Going

Immunotherapy refers to treatments that use the body’s immune system to combat diseases. Immuno-oncology focuses on efforts to use the immune system as a weapon against cancer.  The immune system is a collection of organs, tissues, specialized cells, and substances that protect the body against infection and disease. While the immune system can often handle very small … Read more

Limb-Salvage Surgery Proves Hole-in-One Decision for Pediatric Cancer Survivor

It was quite a spring for Andrew Hedberg. The rising high school sophomore made the varsity golf team and was elected class president for the upcoming school year. Most importantly, the bone cancer that once threatened his left leg and his life remained in remission. All of this validated the decision that Andrew’s family made … Read more

8 Common Childhood Cancer Myths and Questions

Childhood cancer is rare, but when it happens, it usually brings up an endless stream of questions for parents. How did this happen? What will life be like for my child? In this episode of Cancer Mythbusters from Dana-Farber Cancer Institute, we talk about some of the most common questions and myths about childhood cancer … Read more

Facing Ovarian Cancer, a Doctor Becomes the Patient

By Luisa Stigol, MD, FAAP I was a 74-year-old pediatrician in practice with a multi-specialty group associated with Boston Children’s Hospital. Forty years after becoming a doctor, I still loved learning new things and sharing them with my patients. Then I was diagnosed with ovarian cancer — and suddenly, a big wall separated me from … Read more

Overriding Resistance to Epigenetic Inhibitors in Neuroblastoma: Targeting PI3K

This post originally appeared on Vector, Boston Children’s Hospital’s science and clinical innovation blog. Children’s cancers pose unique challenges. They’re not caused by the same kinds of genetic mutations that cause adult cancers, and only a minority of their mutations can be targeted with drugs. In a recent study, Kimberly Stegmaier, MD, at Dana-Farber/Boston Children’s Cancer … Read more